Literature DB >> 8617457

Recurrent Epstein-Barr virus-associated lesions in organ transplant recipients.

T T Wu1, S H Swerdlow, J Locker, D Bahler, P Randhawa, E J Yunis, P S Dickman, M A Nalesnik.   

Abstract

Posttransplant lymphoproliferative disorders (PTLD) are related to Epstein-Barr virus (EBV) and range from lymphoid hyperplasias to lymphomas. The authors report 11 transplant recipients with recurrent EBV-associated lesions. Four patients presented with EBV-positive mononucleosis-like lymphadenitis. One had recurrence of a similar lesion and the other three developed polymorphic PTLDs. Matched clonal studies in one patient showed clonal lymphoid and EB viral populations in the recurrent lesion, but not in the initial lesion. Six patients presented with polymorphic PTLDs. Five later developed histologically dissimilar tumors that resembled non-Hodgkin's lymphoma (two B-cell and one T-cell origin), Hodgkin's disease (one patient), or smooth muscle tumor (one patient). Matched clonal studies were available from one patient and showed that the primary and recurrent lesions were clonally distinct. The sixth patient had recurrence of histologically and clonally identical polymorphic PTLD. One patient presented with monomorphic PTLD and developed recurrence of a clonally identical tumor after a 6-month remission. This study shows that a few patients with EBV-associated lesions have clinical recurrence, which may be either a relapse of the original process or a new EBV-associated lesion. In some patients, the new lesion appeared to represent a more fully developed malignancy that did the antecedent lesion.

Entities:  

Mesh:

Year:  1996        PMID: 8617457     DOI: 10.1016/s0046-8177(96)90369-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  13 in total

1.  Epstein-Barr virus gene expression in post-transplant lymphoproliferative disorders.

Authors:  M Rowe; G Niedobitek; L S Young
Journal:  Springer Semin Immunopathol       Date:  1998

Review 2.  Anaplastic lymphoma kinase (ALK) protein expressing lymphoma after liver transplantation: case report and literature review.

Authors:  V Costes-Martineau; C Delfour; S Obled; L Lamant; G-P Pageaux; P Baldet; P Blanc; G Delsol
Journal:  J Clin Pathol       Date:  2002-11       Impact factor: 3.411

3.  Cytokine mRNA profiles in Epstein-Barr virus-associated post-transplant lymphoproliferative disorders.

Authors:  M A Nalesnik; A Zeevi; P S Randhawa; A Faro; K J Spichty; A J Demetris; J J Fung; T L Whiteside; T E Starzl
Journal:  Clin Transplant       Date:  1999-02       Impact factor: 2.863

Review 4.  Epstein-Barr virus infection and human malignancies.

Authors:  G Niedobitek; N Meru; H J Delecluse
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

5.  Clinicopathologic spectrum and EBV status of post-transplant lymphoproliferative disorders after allogeneic hematopoietic stem cell transplantation.

Authors:  Ding-Bao Chen; Qiu-Jing Song; Yun-Xin Chen; Yu-Hong Chen; Dan-Hua Shen
Journal:  Int J Hematol       Date:  2012-12-20       Impact factor: 2.490

6.  Brain involvement in multicentric Epstein-Barr virus-associated smooth muscle tumours in a child after kidney transplantation.

Authors:  Sabah Boudjemaa; Françoise Boman; Vincent Guigonis; Liliane Boccon-Gibod
Journal:  Virchows Arch       Date:  2004-04       Impact factor: 4.064

7.  Complex genomic rearrangement of ALK loci associated with integrated human Epstein-Barr virus in a post-transplant myogenic liver tumor.

Authors:  Maria Debiec-Rychter; Romaric Croes; Rita De Vos; Peter Marynen; Tania Roskams; Anne Hagemeijer; Rita Lombaerts; Raf Sciot
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

Review 8.  Post-transplant lymphoproliferative disease (PTLD): lymphokine production and PTLD.

Authors:  G Tosato; J Teruya-Feldstein; J Setsuda; S E Pike; K D Jones; E S Jaffe
Journal:  Springer Semin Immunopathol       Date:  1998

9.  Three different histological subtypes of Epstein-Barr virus-negative post-transplant lymphoproliferative disorder in a patient with hepatitis C infection.

Authors:  Mikiko Kobayashi; Naoko Asano; Mana Fukushima; Takayuki Honda
Journal:  Int J Hematol       Date:  2014-05-31       Impact factor: 2.490

10.  Pulmonary re-occurrence of post-transplant lymphoproliferative disease with hypogammaglobulinaemia.

Authors:  Matthias T F Wolf; Eva Mildenberger; Thomas Lennert; Ioannis Anagnostopoulos; Christina Zinn; Karl Paul; Rolf Keitzer; Hans Versmold
Journal:  Eur J Pediatr       Date:  2003-01-28       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.